Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04088136 · ClinicalTrials.gov registry record · NA
Everyday Memory Intervention
A NA study, sponsored by Georgia Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT04088136: Completed NA study, sponsored by Georgia Institute of Technology.
NCT04088136 is a NA study that has completed, run by Georgia Institute of Technology. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04088136, a NA study, has completed, sponsored by Georgia Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
Evaluates an intervention designed to improve everyday memory function, contrasting people receiving the intervention with a group that receives traditional memory strategy training.
Primary Outcome
Across the data collection period, participants audio recorded descriptions of their memory failures on a smartphone app. The audio recordings were transcribed and then cleaned and qualitatively coded so that the number of memory failures each participant reported during the data collection period could be counted. The data was qualitatively coded to ensure an accurate count of the number of memory failures per participant without counting duplicate events or accidental reports. Average daily nu
Interventions
- BEHAVIORAL Everyday Metacognitive Memory Intervention
- BEHAVIORAL Memory Strategy Control Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2021-12-10 |
| Phase | NA |
What the finished NCT04088136 record still lists
NCT04088136 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Everyday Metacognitive Memory Intervention is the first listed.
NCT04088136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04088136 about?
NCT04088136 is a clinical study titled "Everyday Memory Intervention". Evaluates an intervention designed to improve everyday memory function, contrasting people receiving the intervention with a group that receives traditional memory strategy training.
What is the current status of trial NCT04088136?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2021-03-15. Estimated completion is 2021-12-10.
What interventions are being tested in trial NCT04088136?
The interventions under investigation include: Everyday Metacognitive Memory Intervention (BEHAVIORAL), Memory Strategy Control Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04088136?
This trial is sponsored by Georgia Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04088136's enrollment target sits among peer trials
68 1133rd of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI